Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.

A diagnostic model based on delayed post-gadolinium enhancement magnetic resonance imaging improves the accuracy of Meniere disease diagnosis.

HealthDay News — Early-onset neonatal sepsis and meningitis are associated with an increased risk for childhood epilepsy, according to a study published online July 7 in JAMA Network Open.

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications.

HealthDay News — Racial/ethnic and socioeconomic disparities contribute to frequent emergency department visits for seizures, according to a study published online July 5 in Epilepsia.

Nightly sleep duration greater than 9.9 hours in the first week postconcussion is associated with higher symptom burden among adolescents.

Music therapy plus standard analgesia vs standard care alone reduced pain and anxiety in patients with nontrauma-related pain in the emergency department.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Of the 16 available MDD prediction instruments, researchers recommend using those assessing prior treatments and clinical characteristics.

New actigraphy-based algorithm shows TAK-861 significantly increases nap free days and reduces sleep time per day among those with narcolepsy type 1.

HealthDay News — Loneliness is a predictor of depression and poor health outcomes, according to a study published online July 9 in PLOS ONE.